搜索
eXoZymes Inc
EXOZ添加自选
8.575USD
+0.075+0.88%
收盘 07/02, 13:00（美东）报价延迟15分钟
72.71M总市值
亏损市盈率 TTM
关于 eXoZymes Inc 公司
eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
eXoZymes Inc简介
公司代码EXOZ
公司名称eXoZymes Inc
上市日期Nov 13, 2024
CEOHeltzen (Michael)
员工数量31
证券类型Ordinary Share
年结日Nov 13
公司地址750 Royal Oaks Dr
城市MONROVIA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编91016
电话16264151488
网址https://exozymes.com/
公司代码EXOZ
上市日期Nov 13, 2024
CEOHeltzen (Michael)
eXoZymes Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
--
-100.00%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Director
Director
--
--
Dr. James U. Bowie, Ph.D.
Dr. James U. Bowie, Ph.D.
Independent Director
Independent Director
--
--
Dr. James J. (Jim) Lalonde, Ph.D.
Dr. James J. (Jim) Lalonde, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lon Edward Bell, Ph.D.
Dr. Lon Edward Bell, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
--
-100.00%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
常见问题
eXoZymes Inc的前五大股东是谁？
eXoZymes Inc 的前五大股东如下：Dr. Paul Hideo Opgenorth, Ph.D.
有多少机构持有eXoZymes Inc(EXOZ)的股份？
截至2026Q1，共有13家机构持有eXoZymes Inc的股份，合计持有的股份价值约为94.24K，占公司总股份的1.11%。与2025Q4相比，机构持股有所增加，增幅为16676.00。